Protein engineering of NADH pyrophosphatase for efficient biocatalytic production of reduced nicotinamide mononucleotide

Introduction: NADH pyrophosphatase, a hydrolase catalyzing the phosphate bond of NADH to reduced nicotinamide mononucleotide, has potential applications in the food, cosmetic and pharmaceutical industry. Methods: Here, we investigated the effects of vector screening, promoter and RBS strategies on NADH pyrophosphatase expression and protein engineering on its enzymatic activity and thermal stability. Results: In this study, we describe a NADH pyrophosphatase derived from Escherichia coli (EcNudc). Strategies focusing on expression regulation including screening vectors, optimizing promoters and ribosome binding sites were utilized to enhance the productivity of EcNudc (1.8 U/mL). Moreover, protein engineering was adopted to further improve the catalytic properties of EcNudc, achieving 3.3-fold higher activity and 3.6-fold greater thermostability at 50°C. Furthermore, fermentation for the combined mutant R148A-H149E (EcNudc-M) production in a 7 L fermenter was implemented and the enzyme activity of EcNudc-M reached 33.0 U/mL. Finally, the EcNudc-M was applied in the catalysis of NADH with the highest NMNH yield of 16.65 g/L. Discussion: In conclusion, we constructed a commercially available genetically engineered strain with high activity and thermal stability of NADH pyrophosphatase, laying a broad foundation for the biocatalytic industrial production of NMNH and expand its application range.

[1]  Diogo Santos-Martins,et al.  AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings , 2021, J. Chem. Inf. Model..

[2]  C. Bingman,et al.  Biocatalytic synthesis of non-standard amino acids by a decarboxylative aldol reaction , 2021, Nature Catalysis.

[3]  Wenhao Zhang,et al.  Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth. , 2021, Journal of proteome research.

[4]  S. Denis,et al.  Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  F. Shen,et al.  NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin , 2021, Theranostics.

[6]  J. Littlechild,et al.  Structural Insights into a Novel Esterase from the East Pacific Rise and Its Improved Thermostability by a Semirational Design. , 2021, Journal of agricultural and food chemistry.

[7]  Zhenghong Xu,et al.  Fine-Tuning Multi-Gene Clusters via Well-Characterized Gene Expression Regulatory Elements: Case Study of the Arginine Synthesis Pathway in C. glutamicum. , 2020, ACS synthetic biology.

[8]  E. Verdin,et al.  NAD+ metabolism and its roles in cellular processes during ageing , 2020, Nature Reviews Molecular Cell Biology.

[9]  A. Kondo,et al.  Metabolic design for selective production of nicotinamide mononucleotide from glucose and nicotinamide. , 2020, Metabolic engineering.

[10]  José F. Hidalgo,et al.  The first comprehensive phylogenetic and biochemical analysis of NADH diphosphatases reveals that the enzyme from Tuber melanosporum is highly active towards NAD+ , 2019, Scientific Reports.

[11]  Keisuke Hikosaka,et al.  Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases , 2019, Nutritional neuroscience.

[12]  Zhenghong Xu,et al.  Efficient biocatalytic synthesis of nicotinic acid by recombinant nitrilase via high density culture. , 2018, Bioresource technology.

[13]  Tomás Martínek,et al.  HotSpot Wizard 3.0: web server for automated design of mutations and smart libraries based on sequence input information , 2018, Nucleic Acids Res..

[14]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[15]  A. Sahebkar,et al.  Recombinant Protein Expression in Escherichia coli (E.coli): What We Need to Know. , 2018, Current pharmaceutical design.

[16]  D. Spiller,et al.  Mouse Nudt13 is a Mitochondrial Nudix Hydrolase with NAD(P)H Pyrophosphohydrolase Activity , 2017, The Protein Journal.

[17]  M. Hirschey,et al.  Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases , 2017, Nature Reviews Nephrology.

[18]  Torsten Schwede,et al.  The SWISS-MODEL Repository—new features and functionality , 2016, Nucleic Acids Res..

[19]  Jenn-Kang Hwang,et al.  Protein Thermal Stability Enhancement by Designing Salt Bridges: A Combined Computational and Experimental Study , 2014, PloS one.

[20]  Qiang Li,et al.  High activity expression of D-amino acid oxidase in Escherichia coli by the protein expression rate optimization. , 2013, Protein expression and purification.

[21]  L. Bi,et al.  Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation , 2011, Molecular microbiology.

[22]  Christopher A. Voigt,et al.  Automated Design of Synthetic Ribosome Binding Sites to Precisely Control Protein Expression , 2009, Nature Biotechnology.

[23]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[24]  C. Brenner,et al.  Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. , 2008, Annual review of nutrition.

[25]  D. Spiller,et al.  Mammalian NADH diphosphatases of the Nudix family: cloning and characterization of the human peroxisomal NUDT12 protein. , 2003, The Biochemical journal.

[26]  A. McLennan,et al.  The NADH diphosphatase encoded by the Saccharomyces cerevisiae NPY1 nudix hydrolase gene is located in peroxisomes. , 2001, Archives of biochemistry and biophysics.

[27]  D. Frick,et al.  Cloning, Purification, and Properties of a Novel NADH Pyrophosphatase , 1995, The Journal of Biological Chemistry.

[28]  B. Ames,et al.  The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. , 1960, The Journal of biological chemistry.